Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline

Respir Med. 2014 Jul;108(7):976-82. doi: 10.1016/j.rmed.2014.04.014. Epub 2014 May 10.

Abstract

Background: A predominant feature of asthma is an accelerated rate of decline in forced expiratory volume in 1 s (FEV1), but data on the variability and factors associated with this change in patients with controlled asthma are largely unknown.

Methods: 140 patients with controlled asthma were enrolled based on the Global Initiative for Asthma guidelines. We examined the data of a prospective analysis of the association between asthma control and change in FEV1 over time.

Results: A 3-year follow-up assessment was completed in 128 patients. The mean rate of change in FEV1 was a decline of 22.2 mL yr(-1), with significant variation in the levels of change. The between patient standard deviation for the rate of decline was 34.1 mL yr(-1). We next classified the subjects of less than the 25th percentile as rapid decliners, and greater than the 25th percentile as non-rapid decliners. The decrease in the Asthma Control Test score over a 3-year period was higher for rapid decliners than that for non-rapid decliners (p < 0.001). The rapid decliner was more likely to be older, to have higher levels of FeNO, and to have had severe exacerbations during the study. Patients with severe exacerbations had a greater annual decline in FEV1 compared to patients with no exacerbations (-13.6 vs. -53.2 mL yr(-1), p < 0.0001).

Conclusions: Among patients with controlled asthma at baseline, the rate of change in FEV1 is highly variable. Severe exacerbations are strongly associated with a rapid loss of lung function.

Keywords: Airway inflammation; Airway obstruction; Airway remodeling; Asthma exacerbation; Inhaled corticosteroids; Lung function.

MeSH terms

  • Administration, Inhalation
  • Adult
  • Asthma / drug therapy
  • Asthma / physiopathology*
  • Bronchodilator Agents / therapeutic use
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Forced Expiratory Volume / physiology*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Vital Capacity / physiology

Substances

  • Bronchodilator Agents
  • Glucocorticoids